Exploring brain activity changes in Alzheimer's disease

Understanding the structural, functional, and prognostic implications of cortical excitability in Alzheimer's disease

NIH-funded research Beth Israel Deaconess Medical Center · NIH-11084484

This study is looking at how brain activity changes in people with early-stage Alzheimer's disease to help find signs that could show how the disease is progressing and possibly lead to better treatments in the future.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-11084484 on NIH RePORTER

What this research studies

This research investigates how changes in brain activity, specifically cortical excitability, relate to the progression of Alzheimer's disease. Using a technique called transcranial magnetic stimulation combined with electroencephalography (TMS-EEG), the study aims to measure neuronal responses in patients with early-stage Alzheimer's. By understanding these responses, researchers hope to identify important markers that could predict disease progression and potentially guide future treatments.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with early-stage Alzheimer's disease who are experiencing cognitive decline.

Not a fit: Patients with advanced Alzheimer's disease or those without a diagnosis of Alzheimer's may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new ways to assess and treat Alzheimer's disease, improving outcomes for patients.

How similar studies have performed: Previous research has shown promise in using TMS-EEG to assess brain function in various neurological conditions, suggesting potential for success in this area as well.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.